Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP)

European Journal of Clinical Investigation
P Schuff-WernerD Seidel

Abstract

Heparin-induced Extracorporeal LDL-Precipitation (HELP) is an effective procedure for the elimination of both plasma LDL and fibrinogen. In 10 adult patients with severe type II hyperlipoproteinemia, a single HELP treatment of 3 1 plasma led to an acute decrease in the average plasma viscosity (PV) from 1.30 to 1.1 mPas. At the same time, an even more marked decrease in the mean erythrocyte aggregation rate from a pathological value of 7.9% to a value of 3.7% (normal range less than 5%) was observed. Long-term studies on five patients demonstrated a lasting improvement in these two haemorheological variables. The acute rheological changes were also accompanied by an improvement in polarographically determined muscle oxygen tension. Mean oxygen tension values measured in both the m.biceps brachii and the m.tibialis anterior in five patients before and after a single HELP treatment increased from 30 +/- 4 to 37 +/- 7 mmHg and from 27 +/- 2 to 31 +/- 3 mmHg respectively. These results may provide an explanation for the rapid improvement in patients' clinical symptoms such as angina pectoris and in stress electrocardiogram which have been observed during HELP therapy.

References

Jan 1, 1977·The British Journal of Surgery·J C PostlethwaiteJ W Hynd
Sep 1, 1977·Atherosclerosis·H LeonhardtU H Klemens
Mar 1, 1979·Atherosclerosis·D KilpatrickG R Thompson
Jul 1, 1986·Journal of Advanced Nursing·R Messner, M N Smith
Nov 28, 1986·JAMA : the Journal of the American Medical Association·S M Grundy
Nov 7, 1986·Deutsche medizinische Wochenschrift·V HombachW Stoffel
Mar 1, 1987·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·D A EggenC Restrepo
Sep 4, 1987·JAMA : the Journal of the American Medical Association·W B KannelR B D'Agostino
Nov 26, 1987·The New England Journal of Medicine·J B KruskalR E Kirsch
Nov 1, 1985·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·S YokoyamaA Yamamoto
Jun 1, 1985·Biomedizinische Technik. Biomedical Engineering·F JungH Kiesewetter
May 7, 1983·Lancet·D W Huestis
Aug 23, 1984·The New England Journal of Medicine·L WilhelmsenG Tibblin
Sep 15, 1983·The New England Journal of Medicine·M A PirisB Gil
Jan 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·W Stoffel, T Demant
Sep 1, 1982·Biomedizinische Technik. Biomedical Engineering·H KiesewetterH Schmid-Schönbein
Apr 1, 1980·Acta Neurologica Scandinavica·P R HumphreyE Zilkha
Jan 1, 1981·Atherosclerosis·A H SeplowitzF R Smith
May 1, 1964·Journal of Applied Physiology·E W MERRILLF T HATCH

❮ Previous
Next ❯

Citations

Jan 1, 1997·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·A HaasJ Faulborn
Apr 25, 2012·Clinical Research in Cardiology Supplements·K-P MellwigF van Buuren
Sep 26, 2012·Clinical Research in Cardiology Supplements·Peter Schuff-WernerPeter Kohlschein
Mar 6, 2003·Atherosclerosis·Gilbert R Thompson
Aug 12, 1998·Atherosclerosis·K P MellwigG Notohamiprodjo
Jun 27, 2000·Neurobiology of Aging·M Walzl
Dec 1, 2012·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Jochen M GrimmTobias Saam
Dec 14, 2011·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Wai Ping LeeJulian Halcox
Dec 14, 2002·Lancet·M Suckfüll, UNKNOWN Hearing Loss Study Group
Jan 1, 1992·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·D UllrichC Drobik
Apr 5, 2002·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Werner O RichterJens Klinkmann
Jun 3, 2004·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Bernd StegmayrOwe Johnson
Aug 6, 1994·Quality in Health Care : QHC·N BarberS Anderson
Feb 1, 2013·Journal of Nursing Measurement·Caitlin W BrennanJeffrey Van Der Meulen
Jul 11, 1998·Epidemiologia e psichiatria sociale·S Wessely
Jun 22, 2017·The Cochrane Database of Systematic Reviews·Julia BidondeHeather Ja Foulds
Feb 18, 2021·Current Atherosclerosis Reports·Meral Kayikcioglu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.